Tech Company Financing Transactions
LensAR Funding Round
LensAR, based in Orlando, secured $60 million in funding from PDL BioPharma.
Transaction Overview
Company Name
Announced On
10/3/2013
Transaction Type
Debt
Amount
$60,000,000
Round
Undisclosed
Investors
Proceeds Purpose
With this financial commitment from PDL and LENSAR's current equity investors, LENSAR is now fully positioned to address the multi-billion dollar laser addressable cataract surgery market with what we believe to be a superior product.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2800 Discovery Dr.
Orlando, FL 32826
USA
Orlando, FL 32826
USA
Phone
Website
Email Address
Not Recorded
Overview
The LensAR system will not only deliver precise all laser capsulotomies, CCIs and LRIs, but laser fragmentation of the cataract. This approach will significantly reduce, and even eliminate the use of ultrasound power in most cases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nicholas Curtis
Browse more venture capital transactions:
Prev: 10/3/2013: Get Lively venture capital transaction
Next: 10/3/2013: Quixey venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We document every notable VC transaction. All VC database entries reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs